The correlation between ketamine and posttraumatic stress disorder in burned service members - PubMed (original) (raw)
. 2008 Feb;64(2 Suppl):S195-8; Discussion S197-8.
doi: 10.1097/TA.0b013e318160ba1d.
Affiliations
- PMID: 18376165
- DOI: 10.1097/TA.0b013e318160ba1d
The correlation between ketamine and posttraumatic stress disorder in burned service members
Laura L McGhee et al. J Trauma. 2008 Feb.
Abstract
Background: Predisposing factors for posttraumatic stress disorder (PTSD) include experiencing a traumatic event, threat of injury or death, and untreated pain. Ketamine, an anesthetic, is used at low doses as part of a multimodal anesthetic regimen. However, since ketamine is associated with psychosomatic effects, there is a concern that ketamine may increase the risk of developing PTSD. This study investigated the prevalence of PTSD in Operation Iraqi Freedom/Operation Enduring Freedom (OIF/OEF) service members who were treated for burns in a military treatment center.
Methods: The PTSD Checklist-Military (PCL-M) is a 17-question screening tool for PTSD used by the military. A score of 44 or higher is a positive screen for PTSD. The charts of all OIF/OEF soldiers with burns who completed the PCL-M screening tool (2002-2007) were reviewed to determine the number of surgeries received, the anesthetic regime used, including amounts given, the total body surface area burned, and injury severity score. Morphine equivalent units were calculated using standard dosage conversion factors.
Results: The prevalence of PTSD in patients receiving ketamine during their operation(s) was compared with patients not receiving ketamine. Of the 25,000 soldiers injured in OIF/OEF, United States Army Institute of Surgical Research received 603 burned casualties, of which 241 completed the PCL-M. Of those, 147 soldiers underwent at least one operation. Among 119 patients who received ketamine during surgery and 28 who did not; the prevalence of PTSD was 27% (32 of 119) versus 46% (13 of 28), respectively (p = 0.044).
Conclusions: Contrary to expectations, patients receiving perioperative ketamine had a lower prevalence of PTSD than soldiers receiving no ketamine during their surgeries despite having larger burns, higher injury severity score, undergoing more operations, and spending more time in the ICU.
Similar articles
- The relationship of intravenous midazolam and posttraumatic stress disorder development in burned soldiers.
McGhee LL, Maani CV, Garza TH, DeSocio PA, Gaylord KM, Black IH. McGhee LL, et al. J Trauma. 2009 Apr;66(4 Suppl):S186-90. doi: 10.1097/TA.0b013e31819ce2f0. J Trauma. 2009. PMID: 19359964 - The intraoperative administration of ketamine to burned U.S. service members does not increase the incidence of post-traumatic stress disorder.
McGhee LL, Maani CV, Garza TH, Slater TM, Petz LN, Fowler M. McGhee LL, et al. Mil Med. 2014 Aug;179(8 Suppl):41-6. doi: 10.7205/MILMED-D-13-00481. Mil Med. 2014. PMID: 25102548 - Incidence of posttraumatic stress disorder and mild traumatic brain injury in burned service members: preliminary report.
Gaylord KM, Cooper DB, Mercado JM, Kennedy JE, Yoder LH, Holcomb JB. Gaylord KM, et al. J Trauma. 2008 Feb;64(2 Suppl):S200-5; discussion S205-6. doi: 10.1097/TA.0b013e318160ba42. J Trauma. 2008. PMID: 18376167 - Disparate prevalence estimates of PTSD among service members who served in Iraq and Afghanistan: possible explanations.
Ramchand R, Schell TL, Karney BR, Osilla KC, Burns RM, Caldarone LB. Ramchand R, et al. J Trauma Stress. 2010 Feb;23(1):59-68. doi: 10.1002/jts.20486. J Trauma Stress. 2010. PMID: 20135699 Review. - Mild traumatic brain injury and posttraumatic stress disorder in returning veterans: perspectives from cognitive neuroscience.
Vasterling JJ, Verfaellie M, Sullivan KD. Vasterling JJ, et al. Clin Psychol Rev. 2009 Dec;29(8):674-84. doi: 10.1016/j.cpr.2009.08.004. Epub 2009 Aug 21. Clin Psychol Rev. 2009. PMID: 19744760 Review.
Cited by
- Management of critically ill patients in austere environments: good clinical practice by the Italian Society of Anesthesia, Analgesia, Resuscitation and Intensive Care (SIAARTI).
Bixio M, Carenzo L, Accurso G, Balagna R, Bazurro S, Chiarini G, Cortegiani A, Faraldi L, Fontana C, Giannarzia E, Giarratano A, Molineris E, Raineri SM, Marin P. Bixio M, et al. J Anesth Analg Crit Care. 2024 Nov 6;4(1):74. doi: 10.1186/s44158-024-00209-8. J Anesth Analg Crit Care. 2024. PMID: 39506879 Free PMC article. Review. - Neuronal excitation-inhibition imbalance in the basolateral amygdala is involved in propofol-mediated enhancement of fear memory.
Chen C, Li S, Zhou Y, Huang H, Lin JT, Wu WF, Qiu YK, Dong W, Wan J, Liu Q, Zheng H, Wu YQ, Zhou CH. Chen C, et al. Commun Biol. 2024 Oct 29;7(1):1408. doi: 10.1038/s42003-024-07105-5. Commun Biol. 2024. PMID: 39472670 Free PMC article. - Ketamine as a therapeutic agent in major depressive disorder and posttraumatic stress disorder: Potential medicinal and deleterious effects.
Sachdeva B, Sachdeva P, Ghosh S, Ahmad F, Sinha JK. Sachdeva B, et al. Ibrain. 2023 Feb 20;9(1):90-101. doi: 10.1002/ibra.12094. eCollection 2023 Spring. Ibrain. 2023. PMID: 37786516 Free PMC article. Review. - Enhancing Fear Extinction: Pharmacological Approaches.
Ponomareva OY, Fenster RJ, Ressler KJ. Ponomareva OY, et al. Curr Top Behav Neurosci. 2023;64:289-305. doi: 10.1007/7854_2023_443. Curr Top Behav Neurosci. 2023. PMID: 37584834 - Ketamine for Treatment of Posttraumatic Stress Disorder: State of the Field.
Fremont R, Brown O, Feder A, Murrough J. Fremont R, et al. Focus (Am Psychiatr Publ). 2023 Jul;21(3):257-265. doi: 10.1176/appi.focus.20230006. Epub 2023 Jun 28. Focus (Am Psychiatr Publ). 2023. PMID: 37404968 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical